Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 9,295
Sort by:

General Drugs Wholesale Purchasing World Report

US$ 950.00

GENERAL DRUGS WHOLESALE PURCHASING WORLD PDF REPORT See descriptive brochure: here The General Drugs Wholesale Purchasing World Report gives data on a list of 42 categories of Raw Materials, Semi-Finished & ... , by each country, by Year. This General Drugs Wholesale Purchasing World Report is a PDF Summary Edition.802 pages. Updated monthly. UPGRADE: A Purchasing World Database Edition of this report is available ...

September 2019 802 pages

General-Line Drugs Wholesale Revenues Global Report

US$ 950.00

... Coupon value of $300. GENERAL-LINE DRUGS WHOLESALE REVENUES WORLD REPORT DATABASE EDITION The Market for General-Line Drugs Wholesale Revenues in each country by Products & Services. The General-Line Drugs Wholesale Revenues World Report covers ...

September 2019 859 pages

Specialty-Line Drugs Wholesale Revenues Global Report

US$ 950.00

... Coupon value of $300. SPECIALTY-LINE DRUGS WHOLESALE REVENUES WORLD REPORT DATABASE EDITION The Market for Specialty-Line Drugs Wholesale Revenues in each country by Products & Services. The Specialty-Line Drugs Wholesale Revenues World Report covers ...

September 2019 882 pages

Investigation Report on China's Finasteride Market, 2019-2023

US$ 2,200.00

... prostatic hyperplasia in China Status of China's Finasteride market Competition on China's Finasteride market Major Finasteride manufacturers in China Prices of Finasteride in China Major factors influencing the development of China's Finasteride market Prospect of China's Finasteride market from ...

September 2019 30 pages

Investigation Report on China's Pegaspargase Market, 2019-2023

US$ 2,200.00

... of leukemia in China Status of China's Pegaspargase market Retail prices of Pegaspargase in China Major factors influencing the development of China's Pegaspargase market Prospect of China's Pegaspargase market from 2019 to 2023 Progress of generic Pegaspargase in China

September 2019 30 pages

Investigation Report on China's Prothrombin Complex Concentrate (PCC) Market, 2019-2023

US$ 2,200.00

... hemophiliacs in China at the end of 2018. And most of them failed to receive timely treatment because they had no ability to pay. Prothrombin complex concentrate (PCC ... of PCC and there are few manufacturers of PCC in China, China’s PCC market is highly concentrated with CR5 of more than 90%. In 2017, Hualan ...

September 2019 30 pages

Carcinoid Syndrome- Pipeline Insight, 2019

US$ 1,250.00

... Carcinoid Syndrome- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Carcinoid Syndrome pipeline ... 's proprietary databases, company/university websites, clinical trial registries, conferences, ...

August 2019 60 pages

Chagas Disease - Pipeline Insight, 2019

US$ 1,250.00

... Chagas Disease pipeline landscape is provided which includes the disease overview and Chagas Disease treatment guidelines. The assessment part of the report embraces, in depth Chagas Disease commercial assessment and clinical ...

August 2019 60 pages

Chronic Neuropathic Pain (CNP) - Pipeline Insight, 2019

US$ 1,250.00

... disease overview and Chronic Neuropathic Pain treatment guidelines. The assessment part of the report embraces, in depth Chronic Neuropathic Pain commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages

Gorlin Syndrome - Pipeline Insight, 2019

US$ 1,250.00

... Gorlin Syndrome treatment guidelines. The assessment part of the report embraces, in depth Gorlin Syndrome commercial assessment and clinical assessment of the pipeline ... traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor ...

August 2019 60 pages

Graves’ Ophthalmopathy - Pipeline Insight, 2019

US$ 1,250.00

... Graves’ Ophthalmopathy Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC ...

August 2019 60 pages

Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2019

US$ 1,250.00

... therapy (which has been the standard treatment for HSDD for a long time), Testosterone treatment (Menopausal women with HSDD). Hypoactive Sexual Desire Disorder (HSDD) Pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...

August 2019 60 pages

Hypothalamic Obesity (HO) - Pipeline Insight, 2019

US$ 1,250.00

... Hypothalamic Obesity treatment guidelines. The assessment part of the report embraces, in depth Hypothalamic Obesity commercial assessment and clinical assessment of the pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...

August 2019 60 pages

Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2019

US$ 1,250.00

... disease overview and Idiopathic CD4+ Lymphocytopenia treatment guidelines. The assessment part of the report embraces, in depth Idiopathic CD4+ Lymphocytopenia commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages

Lactose Intolerance - Pipeline Insight, 2019

US$ 1,250.00

... Lactose malassimilation. Lactose Intolerance Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... proprietary databases, company/university websites, clinical trial registries, conferences, ...

August 2019 60 pages

Lambert-Eaton Myasthenic Syndrome (LEMS)- Pipeline Insight, 2019

US$ 1,250.00

... disease overview and Lambert-Eaton Myasthenic Syndrome (LEMS) treatment guidelines. The assessment part of the report embraces, in depth Lambert-Eaton Myasthenic Syndrome (LEMS) commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages

Phosphoglucomutase (PGM 1) Deficiency- Pipeline Insight, 2019

US$ 1,250.00

... report which includes Company-Company Collaborations (Licensing / Partnering), Company-Academia Collaborations, and Acquisition analysis in both Graphical and tabulated form. Phosphoglucomutase (PGM 1) Deficiency Clinical Assessment of products ...

August 2019 60 pages

Post-Transplant Lymphoproliferative Disorder- Pipeline Insight, 2019

US$ 1,250.00

... post-transplant lymphoproliferative disease. Early diagnosis and prompt treatment of these disorders are extremely important. Post-Transplant Lymphoproliferative Disorder Pipeline Development Activities The report provides insights ... databases, company/university websites, clinical trial registries, conferences ...

August 2019 60 pages

Primary Biliary Cholangitis - Pipeline Insight, 2019

US$ 1,250.00

... disease overview and Primary Biliary Cholangitis treatment guidelines. The assessment part of the report embraces, in depth Primary Biliary Cholangitis commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages

Primary Progressive Aphasia - Pipeline Insight, 2019

US$ 1,250.00

... disease overview and Primary Progressive Aphasia treatment guidelines. The assessment part of the report embraces, in depth Primary Progressive Aphasia commercial assessment and clinical assessment of the pipeline products under ...

August 2019 60 pages

Proteus Syndrome - Pipeline Insight, 2019

US$ 1,250.00

... Proteus syndrome. Proteus Syndrome Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... 's proprietary databases, company/university websites, clinical trial registries, conferences, SEC ...

August 2019 60 pages

Pruritis - Pipeline Insight, 2019

US$ 1,250.00

... 24 Hours "Pruritis - Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present ... Drugs under development as a monotherapy or combination therapy are also included. It also analyses key players involved in Pruritis ... databases, company/university websites, clinical trial registries, ...

August 2019 60 pages

Pseudoxanthoma Elasticum- Pipeline Insight, 2019

US$ 1,250.00

... Pseudoxanthoma Elasticum- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Pseudoxanthoma Elasticum pipeline ... databases, company/university websites, clinical trial registries, conferences ...

August 2019 60 pages

Pyoderma Gangrenosum (PG) - Pipeline Insight, 2019

US$ 1,250.00

... Pyoderma Gangrenosum treatment guidelines. The assessment part of the report embraces, in depth Pyoderma Gangrenosum commercial assessment and clinical assessment of the pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...

August 2019 60 pages

Recessive Dystrophic Epidermolysis (RDEB)- Pipeline Insight, 2019

US$ 1,250.00

... RDEB-SG. Recessive Dystrophic Epidermolysis Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... 's proprietary databases, company/university websites, clinical trial registries, conferences, ...

August 2019 60 pages

Refractory Epilepsy- Pipeline Insight, 2019

US$ 1,250.00

... Refractory Epilepsy- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Refractory Epilepsy pipeline ... proprietary databases, company/university websites, clinical trial registries, conferences, ...

August 2019 60 pages

Global Acromegaly Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... structured to provide clear and actionable insights into Acromegaly drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Acromegaly Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 78 pages

Global Actinic (Solar) Keratosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Actinic (Solar) Keratosis drugs Late phase: Phase 3 and in-approval Actinic (Solar) Keratosis drugs Companies involved in the Pipeline- Company overview Snapshot Actinic (Solar) Keratosis therapeutic treatment activities Details for each Actinic (Solar) Keratosis drug ...

August 2019 62 pages

Global Alcohol Addiction Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Alcohol Addiction condition and increased access to investments is encouraging growth of Alcohol Addiction drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Alcohol Addiction drug pipeline for companies to optimize spending levels by understanding ...

August 2019 132 pages

Global Anesthetic Effect Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Anesthetic Effect condition and increased access to investments is encouraging growth of Anesthetic Effect drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Anesthetic Effect drug pipeline for companies to optimize spending levels by understanding ...

August 2019 81 pages

Global Angina (Angina Pectoris) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Angina (Angina Pectoris) drugs Late phase: Phase 3 and in-approval Angina (Angina Pectoris) drugs Companies involved in the Pipeline- Company overview Snapshot Angina (Angina Pectoris) therapeutic treatment activities Details for each Angina (Angina Pectoris) drug ...

August 2019 57 pages

Global Arrhythmias Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... structured to provide clear and actionable insights into Arrhythmias drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Arrhythmias Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 60 pages

Global Arterial Thrombosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... of Arterial Thrombosis condition and increased access to investments is encouraging growth of Arterial Thrombosis drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Arterial Thrombosis drug pipeline for companies to optimize spending levels by understanding ...

August 2019 49 pages

Global Atrial Fibrillation Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... of Atrial Fibrillation condition and increased access to investments is encouraging growth of Atrial Fibrillation drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Atrial Fibrillation drug pipeline for companies to optimize spending levels by understanding ...

August 2019 93 pages

Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... in-approval Attention Deficit Hyperactivity Disorder (ADHD) drugs Companies involved in the Pipeline- Company overview Snapshot Attention Deficit Hyperactivity Disorder (ADHD) therapeutic treatment activities Details for each Attention Deficit Hyperactivity Disorder (ADHD ...

August 2019 142 pages

Global Autism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... is structured to provide clear and actionable insights into Autism drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Autism Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 145 pages

Global Axillary Hyperhidrosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... Axillary Hyperhidrosis condition and increased access to investments is encouraging growth of Axillary Hyperhidrosis drug pipeline. However, despite high levels of pipeline activity ... provide clear and actionable insights into Axillary Hyperhidrosis drug pipeline for companies to optimize spending levels by ...

August 2019 45 pages

Global Batten Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Batten Disease condition and increased access to investments is encouraging growth of Batten Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Batten Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 59 pages

Global Behcet Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Behcet Disease condition and increased access to investments is encouraging growth of Behcet Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Behcet Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 47 pages

Global Binge Eating Disorder Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Binge Eating Disorder drugs Late phase: Phase 3 and in-approval Binge Eating Disorder drugs Companies involved in the Pipeline- Company overview Snapshot Binge Eating Disorder therapeutic treatment activities Details for each Binge Eating Disorder drug ...

August 2019 52 pages

Global Bullous Pemphigoid Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... of Bullous Pemphigoid condition and increased access to investments is encouraging growth of Bullous Pemphigoid drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Bullous Pemphigoid drug pipeline for companies to optimize spending levels by understanding ...

August 2019 50 pages

Global Burns Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... is structured to provide clear and actionable insights into Burns drug pipeline for companies to optimize spending levels by understanding competition, their ... quality checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Burns Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 109 pages

Global Canavan Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Canavan Disease condition and increased access to investments is encouraging growth of Canavan Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Canavan Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 35 pages

Global Cancer related Pain Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Cancer related Pain drugs Late phase: Phase 3 and in-approval Cancer related Pain drugs Companies involved in the Pipeline- Company overview Snapshot Cancer related Pain therapeutic treatment activities Details for each Cancer related Pain drug ...

August 2019 125 pages

Global Cerebral Palsy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... causes of Cerebral Palsy condition and increased access to investments is encouraging growth of Cerebral Palsy drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Cerebral Palsy drug pipeline for companies to optimize spending levels by understanding ...

August 2019 40 pages

Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... in-approval Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) drugs Companies involved in the Pipeline- Company overview Snapshot Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) therapeutic treatment activities Details for each Chronic Inflammatory Demyelinating Polyneuropathy (CIDP ...

August 2019 52 pages

Global Chronic Traumatic Encephalopathy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Chronic Traumatic Encephalopathy drugs Late phase: Phase 3 and in-approval Chronic Traumatic Encephalopathy drugs Companies involved in the Pipeline- Company overview Snapshot Chronic Traumatic Encephalopathy therapeutic treatment activities Details for each Chronic Traumatic Encephalopathy drug ...

August 2019 45 pages

Global Chronic Urticaria Or Hives Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 3 and in-approval Chronic Urticaria Or Hives drugs Companies involved in the Pipeline- Company overview Snapshot Chronic Urticaria Or Hives therapeutic treatment activities Details for each Chronic Urticaria Or Hives drug candidate ...

August 2019 65 pages

Global Cluster Headache Syndrome Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... 2 Cluster Headache Syndrome drugs Late phase: Phase 3 and in-approval Cluster Headache Syndrome drugs Companies involved in the Pipeline- Company overview Snapshot Cluster Headache Syndrome therapeutic treatment activities Details for each Cluster Headache Syndrome drug ...

August 2019 45 pages

Global Cognitive Impairment Associated With Schizophrenia (CIAS) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,799.00

... Cognitive Impairment Associated With Schizophrenia (CIAS) drugs Companies involved in the Pipeline- Company overview Snapshot Cognitive Impairment Associated With Schizophrenia (CIAS) therapeutic treatment activities Details for each Cognitive Impairment Associated With ...

August 2019 79 pages

Filters

Search

Publishers

1
318
174
29
4
667
409
35
27
971
77
19
16
425
2
21
1
16
111
1
5
9
2,264
5
4
31
6
142
1
17
15
248
651
89
1
373
26
34
586
1
2
16
6
4
84
36
3
4
2
7
15
53
16
26
83
11
32
8
2
17
109
28
19
4
7
3
324
15
1
23
72
24
29
44
296
17
18
2

Regions

131
40
38
37
37
35
32
21
12
10
10
9
9
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
90
12
354
31
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
38
4
4
3
3
3
1
1
3
9
7,953

Price

Date

Pages

Offers

9
1